Skip to main content
Fig. 6 | AIDS Research and Therapy

Fig. 6

From: Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay

Fig. 6

Number and frequency of HIV-1 drug resistance mutations in all 109 patients from the St. George’s and NHS Lothian cohorts quantified using DEEPGEN™. Primary and secondary/compensatory drug resistance mutations, defined by the Stanford University HIV Drug Resistance Database (http://hivdb.stanford.edu), are indicated as red and grey dots, respectively. The four panels summarize the amino acid substitutions (mutations), and their frequencies within the population, associated with resistance to PIs, NRTIs, NNRTIs, and INSTIs identified in any of the 109 patients

Back to article page